Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Urology-Nephrology
»
Neoplasia/BPH
30. January 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Anzeige
Zoom:
Page 1 of 9252
Articles 1 - 20 / 185032
Effects of silybin on triptorelin-induced bone metabolic abnormalities in prostate cancer revealed based on TMT-based proteomics.
PLoS One
Li J, Lv X, Jiang Y.
PMID: 41610125 [PubMed - indexed for MEDLINE]
Correction: Renal cancer survival in clear cell renal cancer compared to other types of tumor histology: A population-based cohort study.
PLoS One
Sepp T, Poyhonen A, Uusküla A, Kotsar A, Veitonmäki T, Tammela TLJ, Baburin A, Murtola TJ.
PMID: 41610091 [PubMed - in process]
Methylation-specific, universal, and highly sensitive identification of ctDNA in prostate cancer by multiplex droplet digital PCR.
PLoS One
Kahns S, Zedan AH, Aagaard MM, Canto LMD, Kjær-Frifeldt S, Eriksen SV, Madsen CV, Madsen JS, Osther PJS, Hansen TF, Andersen RF.
PMID: 41610073 [PubMed - indexed for MEDLINE]
Comparison of the EORTC QLQ PR25 and the FACT-P for assessing quality of life in patients with prostate cancer - an updated literature review.
Curr Opin Support Palliat Care
Chen D, Jomy J, Ning T, Cheng S, Khan M, Bottomley A, Cella D, Chung H, Lee SF, Emmenegger U, Hird A, Chow E, Wong HCY, Raman S.
PMID: 41610033 [PubMed - indexed for MEDLINE]
Active surveillance for patients with prostate cancer aged ≥75 years: the Prostate Cancer Research International: Active Surveillance (PRIAS)-JAPAN study.
BJU Int
Kato T, Yokomizo A, Matsumoto R, Fukuhara H, Tohi Y, Mori K, Shiota M, Kanno T, Fujii Y, Sakamoto S, Suzuki K, Kojimoto Y, Nakayama M, Goto T, Matsuoka Y, Hashine K, Naya Y, Sakai Y, Sato T, Sugimoto M.
PMID: 41609475 [PubMed - as supplied by publisher]
Phase II Randomized Study of MK-2206 and Bicalutamide in Prostate Cancer Patients With Rising PSA After Primary Therapy (ECOG-ACRIN E2809).
Prostate
Ferrari AC, Chen YH, Rodríguez R, Hudes GR, Antonarakis ES, Hahn NM, Ma H, Plimack ER, Mayer T, Carthon BC, Liu G, Carducci MA, DiPaola R.
PMID: 41609418 [PubMed - as supplied by publisher]
External Validation of the Martini-Klinik Nomogram Predicting the Indication for Adjuvant Radiation Therapy According to EAU Guidelines Among Patients With High-Risk Prostate Cancer After Radical Prostatectomy.
Prostate
Siech C, Brüggemann T, Le QC, Lauer B, Humke C, Preisser F, Maurer T, Kriegmair M, Graefen M, Steuber T, Wenzel M, Chun FKH, Mandel P.
PMID: 41609399 [PubMed - as supplied by publisher]
The Role of Estrogen Signaling Pathway and Targeted Therapy Exploration in Urological Tumors.
Int J Biol Sci
Ma C, Yang L, Li W, Shangguan W, Huang W, Li Z, Sun B, Yang X, Xu H, Li Z, Peng P, Wang Z, Wu P, Cheng B.
PMID: 41608619 [PubMed - indexed for MEDLINE]
Metformin Sensitizes PTEN-deficient Prostate Cancer to PARP Inhibitors by Rebuilding NADP(+) Homeostasis.
Int J Biol Sci
Hao X, Chao Z, Peng H, Guo X, Zheng S, Zhang C, Ding H, Wang Y, Xi Z, Gao Y, Qu G, Zhu Y, Chen Z, Lan P, Li L, Wang Z.
PMID: 41608616 [PubMed - indexed for MEDLINE]
Prevalence and prognostic value of baseline and post-treatment renal insufficiency in colorectal cancer patients: a large retrospective cohort study of 10,581 patients in Shanghai, China (2019-2023).
Front Med (Lausanne)
Li J, Bai CG, Liu B, Pan S, Liu L, Jiang J, Lu J, Cao G, Zhang W, Gao XH.
PMID: 41608452 [PubMed]
Predicting HER2 overexpression in prostate cancer using machine learning: implications for personalized therapy.
Front Oncol
Huang X, Jiang Z, Wang X, Gao J, Li D, Zhang Q, Zhao X, Guo H.
PMID: 41607542 [PubMed]
Development and validation of a nomogram for predicting positive [99mTc]Tc-HYNIC-PSMA SPECT/CT in patients with biochemically recurrent prostate cancer after radical prostatectomy.
Nucl Med Commun
Li B, Yang G, Ding X, Yu Y, Du Y, He F, Li W, Wu X, Gao Y.
PMID: 41607301 [PubMed - as supplied by publisher]
Rectal cancer following radiotherapy for prostate cancer: A propensity-matched analysis.
Colorectal Dis
Goldenshluger M, Abbas MA, Belkovsky M, Alipouriani A, Erozkan K, Alon G, Valente MA, Steele SR, Holubar SD, Liska D, Gorgun E.
PMID: 41606665 [PubMed - indexed for MEDLINE]
Effects of dutasteride with Bacillus Calmette-Guérin therapy on recurrence, progression, metastasis, and survival in non-muscle invasive bladder cancer: a retrospective single-center study.
BMC Urol
Nebio, Ba, Bozlu M, Tek M, Akbay E.
PMID: 41606559 [PubMed - as supplied by publisher]
Semi-supervised learning in prostate MRI tumor detection approaches fully supervised performance on external validation.
Eur Radiol
Pooch EHP, Agrotis G, Cai L, Emberton M, Shah TT, Ahmed HU, Beets-Tan RGH, Benson S, Janssen T, Schoots IG.
PMID: 41606246 [PubMed - as supplied by publisher]
Fecal microbiota transplantation plus immunotherapy in metastatic renal cell carcinoma: the phase 1 PERFORM trial.
Nat Med
Fernandes R, Jabbarizadeh B, Rajeh A, Hong MMY, Baines KJ, Ernst S, Winquist E, Ali AS, Penny S, Figueredo R, Parvathy SN, Lenehan JG, Pinto DM, Silverman MS, Maleki Vareki S.
PMID: 41606120 [PubMed - as supplied by publisher]
Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial.
Nat Med
Porcari S, Ciccarese C, Heidrich V, Rondinella D, Quaranta G, Severino A, Arduini D, Buti S, Fornarini G, Primi F, Stumbo L, Giannarelli D, Giudice GC, Damassi A, Giron Berríos JR, Pun, Barbazuk TB, Piccinno G, Pinto F, Armanini F, Asnicar F, Schinzari G, Derosa L, Kroemer G, Sanguinetti M, Masucci L, Gasbarrini A, Tortora G, Cammarota G, Zitvogel L, Segata N, Iacovelli R, Ianiro G.
PMID: 41606119 [PubMed - as supplied by publisher]
En-bloc resection: Evidence and uncertainty Re: Comparative effectiveness of en-bloc resection techniques vs. conventional transurethral resection for non-muscle-invasive bladder cancer: A systematic review and meta-analysis.
Can Urol Assoc J
Marcq G, Dahm P, Maisch P.
PMID: 41605856 [PubMed]
Micro-ultrasound in the Canadian prostate cancer diagnostic pathway.
Can Urol Assoc J
Millan B, Kinnaird A.
PMID: 41605854 [PubMed]
The Expanding Role of the Urologist in Metastatic Prostate Cancer: From Biopsy to Surgical Interventions.
Rambam Maimonides Med J
Fazaa N, Eigner E, Nsair A, Atallah M, Amiel G, Hoffman A.
PMID: 41605826 [PubMed]
Articles 1 - 20 / 185032
Page 1 of 9252
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy